Willow Biosciences Inc

WLLW.CA

$0.07

Closing

▲5.26%

1D

0.00

YTD

Market cap

$9.36M

52 week high

$0.13

52 week low

$0.04

Volume

17,260

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$9.36M

Analysts' Rating

-

Price Target (Mean)

-

Total Analysts

0

P/E

Operating Margin

-332.20%

Beta

1.06

Revenue Growth (Annual)

-

52 week high

$0.13

52 week low

$0.04

Div. Yield

%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company is developing and commercializing bio-based manufacturing processes and products for its business-to-business (B2B) partners and their customers. The Company is engaged in developing and producing plant derived ingredients for consumer care, food and beverage, and pharmaceutical products. Its FutureGrown biotechnology platform allows production with sustainability at its core. The Company’s commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.